Article
U.S. FDA Approves Cyltezo® (adalimumab-adbm) as First Interchangeable Biosimilar with Humira®
Rating:
0.0
Views:
40
Likes:
1
Library:
1
- Regulatory approval for Interchangeability was supported by positive data from Boehringer Ingelheim's Phase III randomized VOLTAIRE-X clinical trial
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value